Homoarginine and Mortality in Pre-Dialysis Chronic Kidney Disease (CKD) Patients

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Ravani, Pietro ^a   Maas, Renke ^b   Malberti, Fabio ^c   Pecchini, Paola ^c   Mieth, Maren ^b   Quinn, Robert ^a   Tripepi, Giovanni ^d   Mallamaci, Francesca ^d   Zoccali, Carmine ^d  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c Divisione di Nefrologia e Dialisi   (Italy)

^d BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; C REACTIVE PROTEIN; HOMOARGININE; SERUM ALBUMIN;

AGE; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BODY MASS; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PROGNOSIS; PROTEINURIA; RENAL REPLACEMENT THERAPY;

AGED; AGED, 80 AND OVER; FEMALE; HOMOARGININE; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84883389848     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072694     Document Type: Article

References (17)

1. Kielstein JT, Zoccali C, (2008) Asymmetric dimethylarginine: a novel marker of risk and a potential target for therapy in chronic kidney disease. Curr Opin Nephrol Hypertens 17: 609-615.
2. Schwedhelm E, Boger RH, (2011) The role of asymmetric and symmetric dimethylarginines in renal disease. Nat Rev Nephrol 7: 275-285.
3. Baylis C, (2008) Nitric oxide deficiency in chronic kidney disease. Am J Physiol Renal Physiol 294: F1-F9.
4. Zoccali C, (2006) Asymmetric dimethylarginine (ADMA): a cardiovascular and renal risk factor on the move. J Hypertens 24: 611-619.
5. Levillain O, Marescau B, De Deyn PP, (1995) Guanidino compound metabolism in rats subjected to 20% to 90% nephrectomy. Kidney Int 47: 464-472.
6. Valtonen P, Laitinen T, Lyyra-Laitinen T, Raitakari OT, Juonala M, et al. (2008) Serum L-homoarginine concentration is elevated during normal pregnancy and is related to flow-mediated vasodilatation. Circ J 72: 1879-1884.
7. März W, Meinitzer A, Drechsler C, Pilz S, Krane V, et al. (2010) Homoarginine, cardiovascular risk, and mortality. Circulation 122: 967-975.
8. Pilz S, Meinitzer A, Tomaschitz A, Drechsler C, Ritz E, et al. (2011) Low homoarginine concentrations are a novel risk factor for heart diseases. Heart. 97: 1222-1227.
9. Fliser D, (2010) Perspective in renal disease progression: the endothelium as a treatment target in chronic kidney disease. J Nephrol 23: 369-376.
10. Curtis BM, Ravani P, Malberti F, Kennett F, Taylor PA, et al. (2005) The short- and long-term impact of multi-disciplinary clinics in addition to standard nephrology care on patient outcomes. Nephrol Dial Transplant 20: 147-154.
11. Schwedhelm E, Maas R, Tan-Andresen J, Schulze F, Riederer U, et al. (2007) High-throughput liquid chromatographic-tandem mass spectrometric determination of arginine and dimethylated arginine derivatives in human and mouse plasma. J Chromatogr B Analyt Technol Biomed Life Sci 851: 211-219.
12. Atzler D, Mieth M, Maas R, Böger RH, Schwedhelm E, (2011) Stable isotope dilution assay for liquid chromatography-tandem mass spectrometric determination of l-homoarginine in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 879: 2294-2298.
13. Wei LJ, Lin DY, Weissfeld D (1989) Regression analysis of multivariate incomplete failure time data by modeling marginal distributions. J Am Stat Soc 84, 1065-1073.
14. Ravani P, Parfrey P, Gadag V, Malberti F, Barrett B, (2008) Clinical research of kidney diseases V: extended analytic models. Nephrol Dial Transplant 23: 1484-1492.
15. Therneau TM, Grambsch PM Fleming T, (1990) Martingale-Based Residuals for Survival Models. Biometrika 77 1: 147-160.
16. Drechsler C, Kollerits B, Meinitzer A, März W, Ritz E, et al. (2013) Homoarginine and progression of chronic kidney disease: results from the mild to moderate kidney disease study. PLoS One 15 8(5): e63560.
17. Meinitzer A, Puchinger M, Winklhofer-Roob BM, Rock E, Ribalta J, et al. (2007) Reference values for plasma concentrations of asymmetrical dimethylarginine (ADMA) and other arginine metabolites in men after validation of a chromatographic method. Clin Chim Acta 384: 141-148.